latest news on glp 1 drugs GLP-1 Drugs: 6 Things We've Learned About Their Effects With FDA approval of Wegovy
Description
This corresponds with additional fat mass reduction and improved oral glucose control, but not food intake reduction, hinting at a novel MoA as compared to GIPR agonists [29,31,34]
10.1074/jbc.M205055200
If proven true, this would add to our knowledge about the gut-brain connection [19]
18,19 Yet, the glucagonotropic effect of GIP prevails, even during hyperglycaemia (Figure 3B)
:max_bytes(150000):strip_icc()/Wegovy-pill-pic-590ed53ed3304ba8b2388f9d78886dae.png)
10.3892/etm.2019.7347 107 WangL.LiP.TangZ.YanX.FengB
doi: 10.1016/j.jand.2017.06.364
